시장보고서
상품코드
1794535

세계의 오피스 기반 랩 시장

Office-based Labs

발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 279 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 오피스 기반 랩 시장은 2030년까지 346억 달러에 달할 전망

2024년에 242억 달러로 추정되는 세계의 오피스 기반 랩 시장은 2024-2030년에 CAGR 6.1%로 성장하며, 2030년에는 346억 달러에 달할 것으로 예측됩니다. 이 리포트에서 분석한 부문의 하나인 단일 전문 셋업 모델은 CAGR 4.9%를 기록하며, 분석 기간 종료까지 194억 달러에 달할 것으로 예측됩니다. 멀티 스페셜티 셋업 모델 부문의 성장률은 분석 기간 중 CAGR 8.2%로 추정됩니다.

미국 시장은 추정 66억 달러, 중국은 CAGR 9.4%로 성장 예측

미국의 오피스 기반 랩 시장은 2024년에 66억 달러로 추정됩니다. 세계 2위의 경제대국인 중국은 2030년까지 70억 달러의 시장 규모에 달할 것으로 예측되며, 분석 기간인 2024-2030년의 CAGR은 9.4%입니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 3.1%와 5.9%로 예측됩니다. 유럽에서는 독일이 CAGR 4.0%로 성장할 것으로 예측됩니다.

세계의 오피스 기반 랩 시장 - 주요 동향과 촉진요인 정리

오피스 기반 랩(OBL)이 선호되는 의료 서비스 제공 환경으로 부상하는 이유는 무엇인가?

사무실 기반 검사실(OBL)은 다양한 최소 침습적 진단 및 치료 절차에서 병원 치료를 대체할 수 있는 효과적인 대안으로 여겨지고 있습니다. 이러한 시설들은 대부분 인터벤션 심장 전문의, 혈관외과 전문의, 영상의학과 전문의 등의 전문가가 운영하는 경우가 많으며, 의사의 진료실 내에서 치료를 받을 수 있습니다. 이 모델은 일정의 유연성을 향상시킬 뿐만 아니라 병원 인프라에 대한 의존도를 줄여 비용 효율성과 환자 편의성을 모두 향상시킵니다.

많은 의사들에게 OBL 모델은 임상 워크플로우와 환자와의 관계를 더 잘 제어할 수 있습니다. 혈관성형술, 스텐트삽입술, 정맥소작술 등 과거 병원에서만 가능했던 시술도 질과 안전성을 떨어뜨리지 않고 외래에서 안전하게 시행할 수 있게 되었습니다. 환자들은 대기 시간 단축, 병원내 감염 노출 감소, 익숙한 환경에서의 개별화된 진료 등의 혜택을 누리고 있습니다. 분산형 의료 서비스에 대한 수요가 증가함에 따라 OBL은 높은 수준의 의료 서비스를 유지하면서 접근성의 격차를 해소하는 데 도움을 주고 있습니다.

OBL의 성장을 지원하는 기술 혁신과 경영혁신이란?

의료기술의 혁신은 OBL에서 시행할 수 있는 시술의 범위를 크게 확장하고 있습니다. 휴대용 이미징, 카테터 기반 장치, 레이저 시스템 등의 발전으로 소규모의 비병원 환경에서 정밀한 개입이 가능해졌습니다. 이러한 기술은 인프라를 많이 필요로 하지 않기 때문에 설치 비용을 낮추고, 외부 안전 기준 준수를 간소화합니다. 통합 진단 플랫폼, 디지털 워크플로우 툴, 원격 기술 지원은 업무 효율성과 임상 성과를 더욱 향상시킵니다.

운영 모델도 성숙해져 OBL의 설립과 규모 확대가 용이해졌습니다. 많은 의료기관은 현재 실험실 건설, 장비 조달, 직원 교육 등을 턴키 서비스 공급업체와 협력하여 진행하고 있습니다. 또한 개인별 니즈에 맞는 진료비 지원, 규제 관련 컨설팅, 공급망 조정 등을 통해 병원 진료에서 독립적인 외래 진료로 전환하는 의사들을 지원하고 있습니다. 이러한 생태계는 기존의 진입장벽을 상당 부분 제거하여 전문 분야와 지역을 넘어 OBL 모델을 광범위하게 도입할 수 있도록 하고 있습니다.

어떤 시장 및 정책 동향이 오피스 기반 랩(OBL)의 범위를 넓히고 있는가?

의료 시스템은 비용 효율적인 의료 서비스 제공을 적극적으로 추진하고 있으며, OBL은 낮은 운영 비용으로 양질의 서비스를 제공함으로써 이 목표에 부합하고 있습니다. 현재 일부 지역에서 시행되고 있는 진료수가 개혁에서는 OBL에서 시행되는 시술이 병원에서 시행되는 시술과 동일한 보수를 받을 수 있도록 부위 중립성을 지지하고 있습니다. 이는 의료 서비스 프로바이더가 적절한 시술, 낮은 간접비, 보다 합리적인 스케줄링이 가능한 외래 검사실로 전환할 수 있는 강력한 인센티브가 되고 있습니다.

환자들의 선호도도 이러한 변화에 영향을 미치고 있습니다. 현재 많은 환자들이 회복에 소요되는 시간이 짧고, 일상생활에 지장을 최소화하는 편리한 치료를 원하고 있습니다. OBL은 병원 시스템의 복잡성과 비인간성을 피한 환경에서 당일 시술를 제공함으로써 이러한 요구에 부응하고 있습니다. 예방의료의 성장, 만성질환 유병률 증가, 의료서비스가 부족한 지역으로의 확대는 OBL 도입의 또 다른 원동력이 되고 있습니다. OBL 모델에 대한 인식과 신뢰가 높아짐에 따라 이러한 실험실은 전문 클리닉의 성장 전략의 표준이 되고 있습니다.

오피스 기반 랩(OBL) 시장의 성장은 몇 가지 요인에 의해 이루어집니다.

가치 기반 의료로의 전환에 따라 의사들은 임상적 자율성과 비용 효율성을 모두 갖춘 모델을 원하고 있으며, OBL은 안전성을 유지한 채 외래진료를 가능하게 함으로써 이러한 요구에 부응하고 있습니다. 기술 혁신, 특히 소형 중재적 툴와 영상 진단 시스템의 발전으로 사무실 기반 환경에서 안전하게 시행할 수 있는 시술의 범위가 확대되고 있습니다. 저비용 의료 환경을 지지하는 상환 정책의 진화는 지불자와 의료 프로바이더 모두에게 OBL의 경제적 타당성을 강화하고 있습니다. 또한 환자 중심의 치료, 회복 기간 단축, 병원 의존도 감소에 대한 요구가 높아지면서 외래 솔루션에 대한 선호도가 높아지고 있습니다. 검사실 설치, 규정 준수, 직원 배치 등의 지원 체계가 지속적으로 개선됨에 따라 사무실 기반 검사실은 도시와 지방 시장 모두에서 전문 의료 서비스 제공의 핵심 요소가 될 것으로 예측됩니다.

부문

셋업 모델(단일 전문 분야 셋업 모델, 복수 전문 분야 셋업 모델, 하이브리드 셋업 모델); 서비스(말초혈관 인터벤션, 중재적 방사선학, 혈관내치료, 심장혈관, 기타 서비스)

조사 대상 기업의 예

  • Abbott Laboratories
  • ACM Global Laboratories
  • ARUP Laboratories
  • BioReference Laboratories
  • Cleveland Clinic Laboratories
  • DaVita Labs
  • Envision Healthcare
  • Fresenius Medical Care
  • GE Healthcare
  • HCA Healthcare
  • LabCorp(Laboratory Corporation of America)
  • Mayo Clinic Laboratories
  • Mednax(Mednax Lab Services)
  • PPD(Lab Services)
  • Philips(Diagnostic & Point-of-Care Solutions)
  • Quest Diagnostics
  • Siemens Healthineers
  • Sonic Healthcare
  • Thermo Fisher Scientific
  • Trinity Biotech

AI 통합

당사는 유효한 전문가 컨텐츠와 AI 툴에 의해 시장 정보와 경쟁 정보를 변혁하고 있습니다.

Global Industry Analysts는 LLM나 업계 고유 SLM를 조회하는 일반적인 규범에 따르는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수입원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.

목차

제1장 조사 방법

제2장 개요

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSA 25.08.28

Global Office-based Labs Market to Reach US$34.6 Billion by 2030

The global market for Office-based Labs estimated at US$24.2 Billion in the year 2024, is expected to reach US$34.6 Billion by 2030, growing at a CAGR of 6.1% over the analysis period 2024-2030. Single Specialty Set-Up Model, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$19.4 Billion by the end of the analysis period. Growth in the Multi-Specialty Set-Up Model segment is estimated at 8.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$6.6 Billion While China is Forecast to Grow at 9.4% CAGR

The Office-based Labs market in the U.S. is estimated at US$6.6 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$7.0 Billion by the year 2030 trailing a CAGR of 9.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.1% and 5.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.0% CAGR.

Global Office-Based Labs Market - Key Trends & Drivers Summarized

Why Are Office-Based Labs Emerging as a Preferred Healthcare Delivery Setting?

Office-based labs (OBLs) are increasingly seen as an effective alternative to hospital-based care for a variety of minimally invasive diagnostic and therapeutic procedures. These facilities, often operated by specialists such as interventional cardiologists, vascular surgeons, and radiologists, allow treatments to be performed within the physician’s own practice. This model not only improves scheduling flexibility but also reduces reliance on hospital infrastructure, enhancing both cost-efficiency and patient convenience.

For many physicians, the OBL model offers better control over clinical workflows and patient relationships. Procedures that were once limited to hospitals, such as angioplasties, stent placements, and venous ablations, can now be safely performed in outpatient settings without compromising quality or safety. Patients benefit from shorter wait times, reduced exposure to hospital-acquired infections, and personalized care within a familiar environment. As demand grows for decentralized healthcare services, OBLs are helping bridge accessibility gaps while maintaining a high standard of care.

How Are Technological and Operational Innovations Supporting the Growth of OBLs?

Innovations in medical technology are significantly expanding the scope of procedures that can be performed in OBLs. Advances in portable imaging, catheter-based devices, and laser systems have enabled precise interventions in smaller, non-hospital settings. These technologies require less infrastructure, which lowers setup costs and simplifies compliance with outpatient safety standards. Integrated diagnostic platforms, digital workflow tools, and remote technical support further enhance operational efficiency and clinical performance.

Operational models have also matured, making OBLs easier to establish and scale. Many providers now partner with turnkey service vendors for lab construction, equipment procurement, and staff training. Additionally, customized reimbursement support, regulatory consulting, and supply chain coordination are helping physicians navigate the transition from hospital-based practice to independent outpatient care. This ecosystem of support is removing many of the traditional barriers to entry, enabling broader adoption of the OBL model across specialties and geographies.

What Market and Policy Trends Are Expanding the Reach of Office-Based Labs?

Healthcare systems are actively promoting cost-effective care delivery, and OBLs align with this goal by offering high-quality services at lower operational costs. Reimbursement reforms in several regions now support site-of-service neutrality, allowing procedures performed in OBLs to receive similar compensation as those conducted in hospitals. This creates a compelling incentive for providers to shift suitable procedures to outpatient labs, where overheads are lower and scheduling is more streamlined.

Patient preferences are also influencing this shift. Many individuals now seek convenient care experiences with shorter recovery times and minimal disruption to daily routines. OBLs meet this need by offering same-day procedures in a setting that avoids the complexity and impersonality of hospital systems. Growth in preventive care, rising chronic disease incidence, and expansion into underserved areas are further driving adoption. As awareness and trust in the OBL model increase, these labs are becoming a standard part of specialty practice growth strategies.

Growth in the office-based labs market is driven by several factors.

The shift toward value-based care is prompting physicians to seek models that combine clinical autonomy with cost-effectiveness, and OBLs fit this need by enabling outpatient procedures without compromising safety. Technological innovations, particularly in compact interventional tools and imaging systems, are broadening the procedural scope that can be safely delivered in office-based settings. Evolving reimbursement policies that favor lower-cost care environments are reinforcing the financial viability of OBLs for both payers and providers. Additionally, the rising demand for patient-centered care, shorter recovery timelines, and reduced hospital dependency is increasing preference for outpatient solutions. As support systems for lab setup, compliance, and staffing continue to improve, office-based labs are expected to become a core component of specialty care delivery in both urban and regional markets.

SCOPE OF STUDY:

The report analyzes the Office-based Labs market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Set-Up Model (Single Specialty Set-Up Model, Multi-Specialty Set-Up Model, Hybrid Set-Up Model); Service (Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular, Other Services)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

  • Abbott Laboratories
  • ACM Global Laboratories
  • ARUP Laboratories
  • BioReference Laboratories
  • Cleveland Clinic Laboratories
  • DaVita Labs
  • Envision Healthcare
  • Fresenius Medical Care
  • GE Healthcare
  • HCA Healthcare
  • LabCorp (Laboratory Corporation of America)
  • Mayo Clinic Laboratories
  • Mednax (Mednax Lab Services)
  • PPD (Lab Services)
  • Philips (Diagnostic & Point-of-Care Solutions)
  • Quest Diagnostics
  • Siemens Healthineers
  • Sonic Healthcare
  • Thermo Fisher Scientific
  • Trinity Biotech

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Office-based Labs - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Decentralized, Patient-Centric Care Models Drives Growth of Office-Based Labs (OBLs)
    • Expansion of Ambulatory and Outpatient Services Spurs Need for On-Site Diagnostic and Minor Procedure Capabilities
    • Increased Efficiency and Shorter Wait Times Enhance Adoption of OBLs Across Specialties Like Cardiology, Endoscopy, and Urology
    • Shift Toward Value-Based Care Models Throws Spotlight on Cost-Effective and High-Quality In-Office Testing and Treatment
    • Advancements in Portable Diagnostic Equipment and Minimally Invasive Tools Support Broader Lab Functionality
    • Growing Physician Ownership and Autonomy Encourages Investment in Dedicated Office-Based Lab Infrastructure
    • Favorable Reimbursement Policies and CPT Code Expansion Enhance Financial Viability of OBLs
    • Rising Patient Preference for Convenient, Localized Care Boosts Utilization of In-Office Lab Services
    • Integration of Electronic Health Records and Cloud-Based Imaging Systems Improves Workflow and Patient Management
    • Rising Demand for Minimally Invasive Outpatient Procedures Spurs Growth in Office-Based Lab (OBL) Installations
    • Shift Toward Value-Based Healthcare Models Strengthens Business Case for Cost-Efficient OBL Settings
    • Growing Preference Among Physicians for Greater Procedural Autonomy Throws the Spotlight on In-Office Procedure Suites
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Office-based Labs Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Office-based Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Office-based Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Office-based Labs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Single Specialty Set-Up Model by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Single Specialty Set-Up Model by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Single Specialty Set-Up Model by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Multi-Specialty Set-Up Model by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Multi-Specialty Set-Up Model by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Multi-Specialty Set-Up Model by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hybrid Set-Up Model by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Hybrid Set-Up Model by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Hybrid Set-Up Model by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Peripheral Vascular Intervention by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Peripheral Vascular Intervention by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Peripheral Vascular Intervention by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Interventional Radiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Interventional Radiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Interventional Radiology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Endovascular Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Endovascular Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for Endovascular Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Cardiovascular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Cardiovascular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 25: World 16-Year Perspective for Cardiovascular by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Other Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Other Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 28: World 16-Year Perspective for Other Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Office-based Labs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Office-based Labs by Set-Up Model - Percentage Breakdown of Value Sales for Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model for the Years 2014, 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Office-based Labs by Service - Percentage Breakdown of Value Sales for Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Office-based Labs by Set-Up Model - Percentage Breakdown of Value Sales for Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model for the Years 2014, 2025 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Office-based Labs by Service - Percentage Breakdown of Value Sales for Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services for the Years 2014, 2025 & 2030
  • JAPAN
    • Office-based Labs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Office-based Labs by Set-Up Model - Percentage Breakdown of Value Sales for Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model for the Years 2014, 2025 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 46: Japan 16-Year Perspective for Office-based Labs by Service - Percentage Breakdown of Value Sales for Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services for the Years 2014, 2025 & 2030
  • CHINA
    • Office-based Labs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 47: China Recent Past, Current & Future Analysis for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 49: China 16-Year Perspective for Office-based Labs by Set-Up Model - Percentage Breakdown of Value Sales for Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model for the Years 2014, 2025 & 2030
    • TABLE 50: China Recent Past, Current & Future Analysis for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 52: China 16-Year Perspective for Office-based Labs by Service - Percentage Breakdown of Value Sales for Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services for the Years 2014, 2025 & 2030
  • EUROPE
    • Office-based Labs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Office-based Labs by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Office-based Labs by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Office-based Labs by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Office-based Labs by Set-Up Model - Percentage Breakdown of Value Sales for Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model for the Years 2014, 2025 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for Office-based Labs by Service - Percentage Breakdown of Value Sales for Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services for the Years 2014, 2025 & 2030
  • FRANCE
    • Office-based Labs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 62: France Recent Past, Current & Future Analysis for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 64: France 16-Year Perspective for Office-based Labs by Set-Up Model - Percentage Breakdown of Value Sales for Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model for the Years 2014, 2025 & 2030
    • TABLE 65: France Recent Past, Current & Future Analysis for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 67: France 16-Year Perspective for Office-based Labs by Service - Percentage Breakdown of Value Sales for Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services for the Years 2014, 2025 & 2030
  • GERMANY
    • Office-based Labs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for Office-based Labs by Set-Up Model - Percentage Breakdown of Value Sales for Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model for the Years 2014, 2025 & 2030
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 73: Germany 16-Year Perspective for Office-based Labs by Service - Percentage Breakdown of Value Sales for Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for Office-based Labs by Set-Up Model - Percentage Breakdown of Value Sales for Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model for the Years 2014, 2025 & 2030
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 79: Italy 16-Year Perspective for Office-based Labs by Service - Percentage Breakdown of Value Sales for Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Office-based Labs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 80: UK Recent Past, Current & Future Analysis for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 82: UK 16-Year Perspective for Office-based Labs by Set-Up Model - Percentage Breakdown of Value Sales for Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model for the Years 2014, 2025 & 2030
    • TABLE 83: UK Recent Past, Current & Future Analysis for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 85: UK 16-Year Perspective for Office-based Labs by Service - Percentage Breakdown of Value Sales for Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 88: Spain 16-Year Perspective for Office-based Labs by Set-Up Model - Percentage Breakdown of Value Sales for Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model for the Years 2014, 2025 & 2030
    • TABLE 89: Spain Recent Past, Current & Future Analysis for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Spain Historic Review for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 91: Spain 16-Year Perspective for Office-based Labs by Service - Percentage Breakdown of Value Sales for Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 94: Russia 16-Year Perspective for Office-based Labs by Set-Up Model - Percentage Breakdown of Value Sales for Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model for the Years 2014, 2025 & 2030
    • TABLE 95: Russia Recent Past, Current & Future Analysis for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Russia Historic Review for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 97: Russia 16-Year Perspective for Office-based Labs by Service - Percentage Breakdown of Value Sales for Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 16-Year Perspective for Office-based Labs by Set-Up Model - Percentage Breakdown of Value Sales for Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model for the Years 2014, 2025 & 2030
    • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Rest of Europe Historic Review for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 103: Rest of Europe 16-Year Perspective for Office-based Labs by Service - Percentage Breakdown of Value Sales for Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Office-based Labs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Office-based Labs by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Office-based Labs by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Office-based Labs by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 16-Year Perspective for Office-based Labs by Set-Up Model - Percentage Breakdown of Value Sales for Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model for the Years 2014, 2025 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 112: Asia-Pacific 16-Year Perspective for Office-based Labs by Service - Percentage Breakdown of Value Sales for Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Office-based Labs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 115: Australia 16-Year Perspective for Office-based Labs by Set-Up Model - Percentage Breakdown of Value Sales for Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model for the Years 2014, 2025 & 2030
    • TABLE 116: Australia Recent Past, Current & Future Analysis for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Australia Historic Review for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 118: Australia 16-Year Perspective for Office-based Labs by Service - Percentage Breakdown of Value Sales for Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services for the Years 2014, 2025 & 2030
  • INDIA
    • Office-based Labs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 119: India Recent Past, Current & Future Analysis for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 121: India 16-Year Perspective for Office-based Labs by Set-Up Model - Percentage Breakdown of Value Sales for Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model for the Years 2014, 2025 & 2030
    • TABLE 122: India Recent Past, Current & Future Analysis for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: India Historic Review for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 124: India 16-Year Perspective for Office-based Labs by Service - Percentage Breakdown of Value Sales for Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 127: South Korea 16-Year Perspective for Office-based Labs by Set-Up Model - Percentage Breakdown of Value Sales for Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model for the Years 2014, 2025 & 2030
    • TABLE 128: South Korea Recent Past, Current & Future Analysis for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: South Korea Historic Review for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 130: South Korea 16-Year Perspective for Office-based Labs by Service - Percentage Breakdown of Value Sales for Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 16-Year Perspective for Office-based Labs by Set-Up Model - Percentage Breakdown of Value Sales for Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model for the Years 2014, 2025 & 2030
    • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Asia-Pacific Historic Review for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 136: Rest of Asia-Pacific 16-Year Perspective for Office-based Labs by Service - Percentage Breakdown of Value Sales for Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Office-based Labs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Office-based Labs by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Office-based Labs by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Office-based Labs by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 142: Latin America 16-Year Perspective for Office-based Labs by Set-Up Model - Percentage Breakdown of Value Sales for Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model for the Years 2014, 2025 & 2030
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 145: Latin America 16-Year Perspective for Office-based Labs by Service - Percentage Breakdown of Value Sales for Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 148: Argentina 16-Year Perspective for Office-based Labs by Set-Up Model - Percentage Breakdown of Value Sales for Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model for the Years 2014, 2025 & 2030
    • TABLE 149: Argentina Recent Past, Current & Future Analysis for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Argentina Historic Review for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 151: Argentina 16-Year Perspective for Office-based Labs by Service - Percentage Breakdown of Value Sales for Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 154: Brazil 16-Year Perspective for Office-based Labs by Set-Up Model - Percentage Breakdown of Value Sales for Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model for the Years 2014, 2025 & 2030
    • TABLE 155: Brazil Recent Past, Current & Future Analysis for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Brazil Historic Review for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 157: Brazil 16-Year Perspective for Office-based Labs by Service - Percentage Breakdown of Value Sales for Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 160: Mexico 16-Year Perspective for Office-based Labs by Set-Up Model - Percentage Breakdown of Value Sales for Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model for the Years 2014, 2025 & 2030
    • TABLE 161: Mexico Recent Past, Current & Future Analysis for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Mexico Historic Review for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 163: Mexico 16-Year Perspective for Office-based Labs by Service - Percentage Breakdown of Value Sales for Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 16-Year Perspective for Office-based Labs by Set-Up Model - Percentage Breakdown of Value Sales for Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model for the Years 2014, 2025 & 2030
    • TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Rest of Latin America Historic Review for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 169: Rest of Latin America 16-Year Perspective for Office-based Labs by Service - Percentage Breakdown of Value Sales for Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Office-based Labs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Office-based Labs by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Office-based Labs by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Office-based Labs by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 175: Middle East 16-Year Perspective for Office-based Labs by Set-Up Model - Percentage Breakdown of Value Sales for Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model for the Years 2014, 2025 & 2030
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 178: Middle East 16-Year Perspective for Office-based Labs by Service - Percentage Breakdown of Value Sales for Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 181: Iran 16-Year Perspective for Office-based Labs by Set-Up Model - Percentage Breakdown of Value Sales for Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model for the Years 2014, 2025 & 2030
    • TABLE 182: Iran Recent Past, Current & Future Analysis for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Iran Historic Review for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 184: Iran 16-Year Perspective for Office-based Labs by Service - Percentage Breakdown of Value Sales for Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 187: Israel 16-Year Perspective for Office-based Labs by Set-Up Model - Percentage Breakdown of Value Sales for Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model for the Years 2014, 2025 & 2030
    • TABLE 188: Israel Recent Past, Current & Future Analysis for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Israel Historic Review for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 190: Israel 16-Year Perspective for Office-based Labs by Service - Percentage Breakdown of Value Sales for Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 16-Year Perspective for Office-based Labs by Set-Up Model - Percentage Breakdown of Value Sales for Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model for the Years 2014, 2025 & 2030
    • TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Saudi Arabia Historic Review for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 196: Saudi Arabia 16-Year Perspective for Office-based Labs by Service - Percentage Breakdown of Value Sales for Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 199: UAE 16-Year Perspective for Office-based Labs by Set-Up Model - Percentage Breakdown of Value Sales for Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model for the Years 2014, 2025 & 2030
    • TABLE 200: UAE Recent Past, Current & Future Analysis for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: UAE Historic Review for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 202: UAE 16-Year Perspective for Office-based Labs by Service - Percentage Breakdown of Value Sales for Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 16-Year Perspective for Office-based Labs by Set-Up Model - Percentage Breakdown of Value Sales for Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model for the Years 2014, 2025 & 2030
    • TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Rest of Middle East Historic Review for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 208: Rest of Middle East 16-Year Perspective for Office-based Labs by Service - Percentage Breakdown of Value Sales for Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services for the Years 2014, 2025 & 2030
  • AFRICA
    • Office-based Labs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Office-based Labs by Set-Up Model - Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 211: Africa 16-Year Perspective for Office-based Labs by Set-Up Model - Percentage Breakdown of Value Sales for Single Specialty Set-Up Model, Multi-Specialty Set-Up Model and Hybrid Set-Up Model for the Years 2014, 2025 & 2030
    • TABLE 212: Africa Recent Past, Current & Future Analysis for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Africa Historic Review for Office-based Labs by Service - Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 214: Africa 16-Year Perspective for Office-based Labs by Service - Percentage Breakdown of Value Sales for Peripheral Vascular Intervention, Interventional Radiology, Endovascular Therapy, Cardiovascular and Other Services for the Years 2014, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제